The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study)
DIABETES OBESITY & METABOLISM, vol.10, no.12, pp.1239-1247, 2008 (Peer-Reviewed Journal)
Article / Article
DIABETES OBESITY & METABOLISM
Science Citation Index Expanded, Scopus
Aim: To determine if therapeutic management programmes for type 2 diabetes that include self-monitoring of blood glucose (SMBG) result in greater reductions in glycated haemoglobin (HbA1c) compared with programmes without SMBG in non-insulin requiring patients.